Related Experiment Video
Updated: Aug 1, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Pediatric obesity prevention and management
M A Elliott1, N M Copperman, M S Jacobson
1Division of Adolescent Medicine, Center for Atherosclerosis Prevention, Schneider Children's Hospital, New Hyde Park, NY 11040, USA.
Minerva Pediatrica
|July 15, 2004
Summary
Childhood obesity is a global epidemic with no easy cures. This review offers pediatric practitioners guidelines for identifying risk factors and implementing effective prevention strategies for childhood obesity.
Area of Science:
- Pediatrics
- Public Health
- Preventive Medicine
Background:
- Childhood obesity has reached epidemic levels globally, significantly impacting pediatric healthcare.
- Effective pharmacological or surgical treatments for pediatric obesity are currently unavailable.
- Unaddressed obesity can lead to severe, long-term medical complications in children.
Purpose of the Study:
- To provide pediatric practitioners with essential guidelines for childhood obesity prevention.
- To equip healthcare providers with skills for identifying overweight children and associated risk factors.
- To enhance knowledge of available treatment options for pediatric obesity.
Main Methods:
- This review synthesizes current literature on childhood obesity.
- It focuses on identification, risk factors, and prevention strategies.
- Guidelines are presented for pediatric well-care visits.
Main Results:
- Several contributing factors to childhood obesity have been identified.
- Successful prevention programs can be developed based on these factors.
- Practitioners need specific skills for effective intervention.
Conclusions:
- Comprehensive guidelines are necessary for pediatric obesity prevention.
- Early identification and intervention are crucial.
- Pediatric practitioners play a vital role in combating this epidemic.
Related Concept Videos
01:30Preventive Healthcare Services
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...